Last reviewed · How we verify

NCT03427203

Assessment of New Ostomy Devices in Subjects Having an Ileostomy

Completed NA Last updated 6 June 2018
What this trial tests

NA trial testing SenSura Mio in Ileostomy - Stoma in 35 participants. Completed in 6 April 2018.

Timeline
9 January 2018
Primary endpoint
6 April 2018
6 April 2018

Quick facts

Lead sponsorColoplast A/S
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposesupportive care
Enrollment35
Start date9 January 2018
Primary completion6 April 2018
Estimated completion6 April 2018
Sites3 locations across Denmark, Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Coloplast A/S — full company profile →

Who can join

18 and older, any sex, with Ileostomy - Stoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study investigates the performance of three new adhesives with regard to leakage and the skin condition.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical Measurement of Transepidermal Water Loss.
    Kundu D, Jayaraman A, Sen CK. · · 2026 · cited 4× · PMID 40476522 · DOI 10.1089/wound.2024.0148

Verify or expand the search:

Other recruiting trials for Ileostomy - Stoma

Currently open trials in the same condition.

Other Coloplast A/S trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03427203.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing